Conversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIV
Lévi, F.A., Boige, V., Hebbar, M., Smith, D., Lepère, C., Focan, C., Karaboué, A., Guimbaud, R., Carvalho, C., Tumolo, S., Innominato, P., Ajavon, Y., Truant, S., Castaing, D., De Baere, T., Kunstlinger, F., Bouchahda, M., Afshar, M., Rougier, P., Adam, R., Ducreux, M.
Published in Annals of oncology (01.02.2016)
Published in Annals of oncology (01.02.2016)
Get full text
Journal Article
Effect of immunotherapy-infusion time of day on survival of patients with advanced cancers: a study-level meta-analysis
Landré, T., Karaboué, A., Buchwald, Z.S., Innominato, P.F., Qian, D.C., Assié, J.B., Chouaïd, C., Lévi, F., Duchemann, B.
Published in ESMO open (01.02.2024)
Published in ESMO open (01.02.2024)
Get full text
Journal Article
FOLFIRINOX as a first-line chemotherapy for patients (pts) with advanced biliary tract cancer (BTC)
Ulusakarya, A., Karray, W., Abdou, J., Karaboué, A., Haydar, M., Krimi, S., Gumus, Y., Almohamad, W., Goldschmidt, E., Biondani, P., Morère, J.F.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Cetuximab efficacy and safety in a retrospective cohort of elderly patients with heavily pretreated metastatic colorectal cancer
Bouchahda, M, Macarulla, T, Spano, J.P, Bachet, J.B, Lledo, G, Andre, T, Landi, B, Tabernero, J, Karaboué, A, Domont, J, Levi, F, Rougier, P
Published in Critical reviews in oncology/hematology (01.09.2008)
Published in Critical reviews in oncology/hematology (01.09.2008)
Get full text
Journal Article
Feasibility of cetuximab given with a simplified schedule every 2 weeks in advanced colorectal cancer: a multicenter, retrospective analysis
Bouchahda, M., Macarulla, T., LIedo, G., Lévi, F., Elez, M. E., Paule, B., Karaboué, A., Artru, P., Tabernero, J., Machover, D., Innominato, P., Goldschmidt, E., Bonnet, D., Ducreux, M., Castagne, V., Guimbaud, R.
Published in Medical oncology (Northwood, London, England) (01.12.2011)
Published in Medical oncology (Northwood, London, England) (01.12.2011)
Get full text
Journal Article
Circadian and chemotherapy-related changes in urinary modified nucleosides excretion in patients with metastatic colorectal cancer
Dulong, S., Huang, Q., Innominato, P. F., Karaboue, A., Bouchahda, M., Pruvost, A., Théodoro, F., Agrofoglio, L. A., Adam, R., Finkenstädt, B., Lévi, F.
Published in Scientific reports (14.12.2021)
Published in Scientific reports (14.12.2021)
Get full text
Journal Article
Universal Access to Advanced Imaging and Healthcare Protection: UHC and Diagnostic Imaging
Cappabianca, Pietro, Russo, Gaetano Maria, Atripaldi, Umberto, Gallo, Luigi, Rocco, Maria Paola, Pasceri, Giovanni, Karaboue, Michele A A, Angioi, Silvia, Cappabianca, Salvatore, Reginelli, Alfonso
Published in Medical sciences (Basel) (27.09.2021)
Published in Medical sciences (Basel) (27.09.2021)
Get full text
Journal Article
592P - Undetectable RAS mutant clones in plasma: Possible implication for therapy and prognosis in the patient with RAS mutant metastatic colorectal cancer?
Bouchahda, M., Karaboué, A., Saffroy, R., Hamelin, J., Bosselut, N., Lemoine, A.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
592PUndetectable RAS mutant clones in plasma: Possible implication for therapy and prognosis in the patient with RAS mutant metastatic colorectal cancer?
Bouchahda, M, Karaboué, A, Saffroy, R, Hamelin, J, Bosselut, N, Lemoine, A
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Undetectable RAS mutant clones in plasma: Possible implication for therapy and prognosis in the patient with RAS mutant metastatic colorectal cancer?
Bouchahda, M., Karaboué, A., Saffroy, R., Hamelin, J., Bosselut, N., Lemoine, A.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Sex-related differences in circadian-dependent tolerance of Irinotecan (I) added to chronomodulated (chrono) 5-Fluorouracil (F), Leucovorin (L) and Oxaliplatin (O): Final results from international randomised time-finding study in patients with metastatic colorectal cancer (MCC)
Levi, F., Garufi, C., Karaboué, A., Focan, C., Chollet, P., Li, X-M., INNOMINATO, P.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Multidimensional telemonitoring of cancer patients (pts) receiving chronomodulated (chrono) Irinotecan (I), 5-fluorouracil (F), leucovorin (L) and oxaliplatin (O; chronoIFLO4) combination at home
Innominato, P., Komarzynski, S., Bouchahda, M., Ulusakarya, A., Haydar, M., Karaboué, A., Levi, F.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Efficacy and tolerability of chronomodulated FOLFIRINOX (chronoIFLO) as 1st or 2nd line treatment in patients (pts) with metastatic colorectal cancer (MCC): Final results from an international trial (EORTC 05011)
Garufi, C., Levi, F., Karaboué, A., Torsello, A., Focan, C., Chollet, P., INNOMINATO, P.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
761PFOLFIRINOX as a first-line chemotherapy for patients (pts) with advanced biliary tract cancer (BTC)
Ulusakarya, A, Karray, W, Abdou, J, Karaboué, A, Haydar, M, Krimi, S, Gumus, Y, Almohamad, W, Goldschmidt, E, Biondani, P, Morère, J F
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Chemotherapy-induced neutropenia (neutro) association with survival in metastatic colorectal cancer (MCC): Schedule dependency
Innominato, P. F., Giacchetti, S., Småland, R., Focan, C. N. J., Garufi, C., Bjarnason, G. A., Iacobelli, S., Tumolo, S., Karaboué, A., Levi, F.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Pharmacokinetic-pharmacodynamic analysis of hepatic artery infusion of three-drug chronomodulated chemotherapy and intravenous cetuximab in patients with liver metastases from colorectal cancer registered in OPTILIV, a European multicenter phase II trial
Levi, F., Karaboué, A., Etienne-Grimaldi, M., Chatelut, E., Innominato, P. F., Paintaud, G., Loukakos, P., Adam, R., Bouchahda, M., Milano, G.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Chemotherapy-induced neutropenia association with survival in metastatic colorectal cancer (MCC): Schedule dependency
Innominato, P. F., Giacchetti, S., Smaaland, R., Focan, C. N., Garufi, C., Bjarnason, G. A., Iacobelli, S., Tumolo, S., Karaboué, A., Levi, F.
Published in Journal of clinical oncology (01.02.2011)
Published in Journal of clinical oncology (01.02.2011)
Get full text
Journal Article
Safety and efficacy of neoadjuvant combination of hepatic artery infusion (HAI) of irinotecan, 5-fluorouracil, and oxaliplatin with intravenous (iv) cetuximab in patients with unresectable liver metastases from colorectal cancer (CRC): Interim report from OPTILIV—A European multicenter phase II trial
Ducreux, M., Rougier, P., Smith, D., Focan, C. N. J., Innominato, P. F., Bouchahda, M., Ajavon, Y., Castaing, D., De Baere, T., Karaboué, A., Lepere, C., Boige, V., Adam, R., Levi, F.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Optimal control of liver metastases with intravenous cetuximab and hepatic artery infusion of three-drug chemotherapy in patients with liver-only metastases from colorectal cancer: A European multicenter phase II trial
Levi, F., Bouchahda, M., Ducreux, M., Karaboué, A., Focan, C. N., Rougier, P., Innominato, P., Smith, D., Awad, S., Adam, R.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
Efficacy and safety of cetuximab (C) given with a simplified, every other week (q2w), schedule in patients (pts) with advanced colorectal cancer (aCRC): A multicenter, retrospective study
Bouchahda, M., Macarulla, T., LIedo, G., Lévi, F., Elez, M. E., Karaboué, A., Artru, P., Tabernero, J., Castagne, V., Gimbaud, R.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article